DE69510336T2 - Verfahren zur diagnose von praeklampsie - Google Patents

Verfahren zur diagnose von praeklampsie

Info

Publication number
DE69510336T2
DE69510336T2 DE69510336T DE69510336T DE69510336T2 DE 69510336 T2 DE69510336 T2 DE 69510336T2 DE 69510336 T DE69510336 T DE 69510336T DE 69510336 T DE69510336 T DE 69510336T DE 69510336 T2 DE69510336 T2 DE 69510336T2
Authority
DE
Germany
Prior art keywords
praeklampsy
diagnosing
csf
methods
preeclampsia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69510336T
Other languages
English (en)
Other versions
DE69510336D1 (de
Inventor
James Keith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genetics Institute LLC
Virginia Tech Intellectual Properties Inc
Original Assignee
Genetics Institute LLC
Virginia Polytechnic Institute and State University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Institute LLC, Virginia Polytechnic Institute and State University filed Critical Genetics Institute LLC
Application granted granted Critical
Publication of DE69510336D1 publication Critical patent/DE69510336D1/de
Publication of DE69510336T2 publication Critical patent/DE69510336T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2073—IL-11
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE69510336T 1994-03-10 1995-03-10 Verfahren zur diagnose von praeklampsie Expired - Lifetime DE69510336T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/212,446 US5543138A (en) 1994-03-10 1994-03-10 Methods of diagnosing and treating preeclampsia
PCT/US1995/002771 WO1995024650A2 (en) 1994-03-10 1995-03-10 Methods of diagnosing and treating preeclampsia

Publications (2)

Publication Number Publication Date
DE69510336D1 DE69510336D1 (de) 1999-07-22
DE69510336T2 true DE69510336T2 (de) 2000-02-24

Family

ID=22791053

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69510336T Expired - Lifetime DE69510336T2 (de) 1994-03-10 1995-03-10 Verfahren zur diagnose von praeklampsie

Country Status (12)

Country Link
US (2) US5543138A (de)
EP (1) EP0749582B1 (de)
JP (2) JP4149512B2 (de)
KR (1) KR100350259B1 (de)
AT (1) ATE181422T1 (de)
AU (1) AU682593B2 (de)
CA (1) CA2184920C (de)
DE (1) DE69510336T2 (de)
DK (1) DK0749582T3 (de)
ES (1) ES2138729T3 (de)
GR (1) GR3031250T3 (de)
WO (1) WO1995024650A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6126933A (en) * 1995-06-27 2000-10-03 Genetics Institute Methods of treating inflammatory bowel diseases by administering IL-11
US6540993B1 (en) 1995-06-27 2003-04-01 Wyeth Method of treating inflammatory bowel disease using a topical formulation of IL-11
US5679339A (en) * 1995-06-27 1997-10-21 Keith; James Method of using IL-11 for treating spondyloarthropies
US6620590B2 (en) 1996-07-11 2003-09-16 Isis Innovation Limited Diagnosis of pre-eclampsia
AUPO439396A0 (en) * 1996-12-24 1997-01-23 Walter And Eliza Hall Institute Of Medical Research, The A method of treatment and prophylaxis
AU739063B2 (en) * 1996-12-24 2001-10-04 Walter And Eliza Hall Institute Of Medical Research, The A method of treatment and prophylaxis
GB9927125D0 (en) * 1999-11-16 2000-01-12 Univ Reading The Placental human neurokinin B precursor
US6642055B1 (en) 2000-03-31 2003-11-04 Arbogast Pharmaceuticals, Inc. Method for the prediction of preeclampsia and other diseases
US7435419B2 (en) * 2002-07-19 2008-10-14 Beth Israel Deaconess Medical Center Methods of diagnosing and treating pre-eclampsia or eclampsia
US7335362B2 (en) * 2002-07-19 2008-02-26 Beth Israel Deaconess Medical Center Methods of treating pre-eclampsia or eclampsia
KR101215701B1 (ko) * 2002-07-19 2012-12-26 베스 이스라엘 데코니스 메디칼 센터 자간전증 또는 자간의 진단 및 치료 방법
BRPI0407213A (pt) * 2003-02-04 2006-02-07 Univ Tulane Método de emprego da elevação de marinobufagenina na determinação da presença de pré-eclampsia e aparelhos relacionados
WO2005017192A2 (en) * 2003-08-14 2005-02-24 The General Hospital Corporation Screening for gestational disorders
JP4568282B2 (ja) * 2003-09-23 2010-10-27 ザ ジェネラル ホスピタル コーポレイション 妊娠性疾患のスクリーニング
WO2005110462A2 (en) * 2004-05-04 2005-11-24 Children's Medical Center Corporation Methods and compositions for treatment of preeclampsia
US20060024677A1 (en) * 2004-07-20 2006-02-02 Morris David W Novel therapeutic targets in cancer
US7740849B2 (en) * 2004-09-24 2010-06-22 Beth Israel Deaconess Medical Center Use of compounds that bind soluble endoglin and SFLT-1 for the treatment of pregnancy related hypertensive disorders
MX2007003522A (es) * 2004-09-24 2007-06-11 Beth Israel Hospital Complicaciones del embarazo.
US7955805B2 (en) * 2004-12-15 2011-06-07 Beth Israel Deaconess Medical Center Nucleic acids and polypeptides useful for diagnosing complications of pregnancy
US20060212484A1 (en) * 2005-03-18 2006-09-21 Chaffin David G Jr System and method for evaluating, monitoring, diagnosing, and treating hypertension and other medical disorders
US20090286271A1 (en) * 2006-05-31 2009-11-19 Karumanchi Ananth S Methods of Diagnosing and Treating Complications of Pregnancy
CN102316715B (zh) 2008-12-19 2016-03-23 巴斯德生物科学有限公司 使用种子包衣中的巴氏杆菌孢子防治线虫的材料和方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198366A (en) * 1986-03-23 1993-03-30 Technion Research & Development Foundation Ltd. Method for the detection of pregnancy disorders
US4868119A (en) * 1986-12-11 1989-09-19 Genetics Institute, Inc. Hematopoietic growth factors
US4879227A (en) * 1986-05-06 1989-11-07 Genetics Institute, Inc. Production of a recombinant human colony stimulating factor
US5079171A (en) * 1988-09-15 1992-01-07 Adeza Biomedical Corporation Determining pregnancy induced hypertension and eclampsia by immunoassay of cellular fibronectin
WO1990007122A1 (en) * 1988-12-14 1990-06-28 The Regents Of The University Of California Diagnostic assay for the detection of preeclampsia
US5211947A (en) * 1988-12-16 1993-05-18 Schering Corporation Method for lowering blood cholesterol levels with granulocyte-macrophage colony stimulating factor
DE69231636T2 (de) * 1991-11-04 2001-05-23 Adeza Biomedical Corp Screeningverfahren zur identifizierung von frauen mit erhöhtem frühgeburtsrisiko

Also Published As

Publication number Publication date
ES2138729T3 (es) 2000-01-16
JP3741697B2 (ja) 2006-02-01
CA2184920C (en) 2007-10-30
EP0749582B1 (de) 1999-06-16
GR3031250T3 (en) 1999-12-31
DK0749582T3 (da) 1999-11-22
US5543138A (en) 1996-08-06
AU682593B2 (en) 1997-10-09
CA2184920A1 (en) 1995-09-14
JP2004029031A (ja) 2004-01-29
DE69510336D1 (de) 1999-07-22
KR100350259B1 (ko) 2002-10-18
WO1995024650A2 (en) 1995-09-14
ATE181422T1 (de) 1999-07-15
EP0749582A1 (de) 1996-12-27
US5580554A (en) 1996-12-03
JPH09510292A (ja) 1997-10-14
WO1995024650A3 (en) 1995-10-05
AU2095495A (en) 1995-09-25
JP4149512B2 (ja) 2008-09-10

Similar Documents

Publication Publication Date Title
DE69510336D1 (de) Verfahren zur diagnose von praeklampsie
EP1099102A4 (de) Spurendetektion von analyten mit hilfe artifizieller olfaktometrie
DE3788787D1 (de) EINRICHTUNG ZUR EINSTELLUNG EINES HöRGERÄTES DURCH DEN PATIENTEN , VERFAHREN UND TESTEINRICHTUNG FÜR DIESES HöRGERÄT.
DE69334246D1 (de) Verbesserte reagentien und methoden zur diagnose und behandlung von diabetes und stiff man syndrome
DE69510810D1 (de) Lamanin-ketten: diagnostische und therapeutische verwendung
DE69626683T2 (de) Verfahren zur feststellung von antipolymerantikörper und diagnosetestsatz zur feststellung von siliconabhängigen krankheiten
DE69725606D1 (de) Methoden für die diagnose von allergischen atemwegsaspergillosen
ATE126599T1 (de) Verfahren zur bestimmung von anti-rns- antikörpern.
DK0764273T3 (da) Alfa B crystallin til anvendelse i diagnose og terapi af autoimmune sygdomme, især multipel sklerose
DE60038614D1 (de) Verfahren zur diagnose von synovialen oder osteoartikulären erkrankungen
ATE275268T1 (de) Verfahren zur diagnose von sjögren-syndrom
WO1992005278A3 (en) Method for the determination of the differential expression of mrna for the amyloid precursor protein (app)
DE69013139D1 (de) Mittel zur Vorbeugung, Diagnose und Therapie von rheumatischen, autoimmunen, Haut- und Bindegewebekrankheiten von unbekannter Aetiologie und Verfahren zu seiner Herstellung und Verwendung.
DK0745221T3 (da) Pyridinolin krydsbindinger som markører for periodontal og peri-implantat og sygdomsaktivitet
ATE243320T1 (de) Diagnostische verfahren und zusammensetzungen auf basis der verteilung von rad51
ATE228250T1 (de) Diagnosehilfe sowie verfahren zum nachweis der trächtigkeit von wiederkäuern
UA33330A (uk) Спосіб діагностики ендогенної інтоксикації
DE69725333D1 (de) Verfahren zur bestimmung eines erhöhten sterblichkeitsrate
ATA46186A (de) Verfahren zum nachweis von antikoerpern, und mittel zum nachweis von antikoerpern und verfahren zur herstellung des mittels
ATE66109T1 (de) Verfahren zur diagnose und pruefung eines schnittstellenbausteins.
UA36246A (uk) Спосіб діагностики і препарування прихованих каріозних уражень апроксимальних поверхонь молярів нижче екватору
UA23312A (uk) Спосіб діагhостики холелітіазу
RU2001134887A (ru) Способ оценки апоптоза лимфоцитов периферической крови у больных различными формами пиелонефрита
UA23907A (uk) Спосіб діагностики якості ремісії при шизофренії
UA31310A (uk) Спосіб лікування хворих на розсіяний склероз

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: GENETICS INSTITUTE, INC., CAMBRIDGE, MASS., US VIR

8327 Change in the person/name/address of the patent owner

Owner name: GENETICS INSTITUTE,LLC(N.D.GES.D.STAATES DELAWARE)

Owner name: VIRGINIA TECH INTELLECTUAL PROPERTIES INC., BLACKS